3,6,2',4',5'-pentahydroxyflavone, an orally bioavailable multiple protein kinase inhibitor, overcomes gefitinib resistance in non-small cell lung cancer
Yuqiao Sheng, Wei Li, Feng Zhu, Kangdong Liu, Hanyong Chen, Ke Yao, Kanamata Reddy, Do Young Lim, Naomi Oi, Haitao Li, Cong Peng, Wei Ya Ma, Ann M. Bode, Ziming Dong, Zigang Dong
Dive into the research topics of '3,6,2',4',5'-pentahydroxyflavone, an orally bioavailable multiple protein kinase inhibitor, overcomes gefitinib resistance in non-small cell lung cancer'. Together they form a unique fingerprint.